Some leading medical experts have decided to end an age-old tradition — taking money from drug companies. These doctors used to get paid for making speeches. But they say they're reclaiming their tarnished credibility.
Madeleine Brand talks to Peter Libby, chief of cardiovascular medicine at Brigham and Women's Hospital in Boston, about his decision.
Dr. Libby has disclosed that he has served as a consultant for AstraZeneca Pharmaceuticals LP; AtheroGenics, Inc.; Boehringer Ingleheim; Bristol-Myers Squibb Company; GlaxoSmithKline; Interleukin Genetics; Kowa Research Institute; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Sanofi-Aventis; and Schering-Plough Corporation. He has participated in Speakers Bureau activities for AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi-Aventis.
Listern here.
Madeleine Brand talks to Peter Libby, chief of cardiovascular medicine at Brigham and Women's Hospital in Boston, about his decision.
Dr. Libby has disclosed that he has served as a consultant for AstraZeneca Pharmaceuticals LP; AtheroGenics, Inc.; Boehringer Ingleheim; Bristol-Myers Squibb Company; GlaxoSmithKline; Interleukin Genetics; Kowa Research Institute; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Sanofi-Aventis; and Schering-Plough Corporation. He has participated in Speakers Bureau activities for AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi-Aventis.
Listern here.
2 comments:
Why not ask Dr Libby to return all the money he has taken over the years so that he can cleanse his soul completely. He comes across as a self righteous arrogant physician.
Post a Comment